anthrax
First Light Diagnostics Gets FDA Clearance for Anthrax Toxin Test
The 20-minute test is cleared for use on First Light's MultiPath benchtop immunofluorescence analyzer instrument.
T2 Biosystems Gets FDA 510(k) Clearance for Biothreat Panel
The clearance allows the firm to immediately begin marketing an assay that simultaneously detects six biothreat pathogens directly from blood.
Despite recent struggles, the firm remains optimistic about its position as the first and only direct-from-blood sepsis test system.
FDA Grants Marketing Rights for InBios Point-of-Care Anthrax Test
The test, which diagnoses inhalation anthrax, provides results in about 20 minutes and is intended for use by military personnel and medical or healthcare professionals.
BARDA Awards Additional $4M to First Light Diagnostics for Rapid Anthrax Test
The company said that it will use the additional funding to complete product development in support of an FDA submission for its SensiTox B. anthracis Toxin Test.
Jul 29, 2019
Oct 5, 2017